GlassScriptPhysician profile
Molly Dorroh
NPI 1194216366
$5,110.16
in general payments reported to CMS, 2019-2025
11 companies · $1,349 in 2025
The $1,349 reported for 2025 was more than what 87% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.22 · 2020: $15.26 · 2021: $27.39 · 2022: $78.36 · 2024: $3,624 · 2025: $1,349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,315 · Consulting Fee: $750 · Food and Beverage: $582 · Education: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,315.47 |
| Consulting Fee | $750.00 |
| Food and Beverage | $582.46 |
| Education | $325.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $1,843.20 | 2024-2025 | |
| Boston Scientific Corporation | $1,764.25 | 2024 | |
| Axonics, INC. | $766.20 | 2024 | Bulkamid, Axonics |
| Medical Device Business Services, INC. | $325.00 | 2025 | |
| Hologic Sales and Service, LLC | $257.23 | 2025 | Myosure Tissue Removal Device, Acessa Provu System, Fluent Fluid Management System |
| Myovant Sciences INC. | $78.36 | 2022 | |
| Coopersurgical, INC. | $17.05 | 2025 | Paragard T 380a |
| Gilead Sciences, INC. | $16.22 | 2019 | |
| Abbvie INC. | $15.78 | 2021 | |
| Amag Pharmaceuticals, INC. | $15.26 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $11.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Molly Dorroh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.